BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2498314)

  • 1. Effects of cellular transformation on expression of plasminogen activator inhibitors 1 and 2. Evidence for independent regulation.
    Cohen RL; Niclas J; Lee WM; Wun TC; Crowley CW; Levinson AD; Sadler JE; Shuman MA
    J Biol Chem; 1989 May; 264(14):8375-83. PubMed ID: 2498314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2.
    Medcalf RL; Van den Berg E; Schleuning WD
    J Cell Biol; 1988 Mar; 106(3):971-8. PubMed ID: 3126194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-alpha regulates mRNA for urokinase-type plasminogen activator and type-1 plasminogen activator inhibitor in human neoplastic cell lines.
    Georg B; Helseth E; Lund LR; Skandsen T; Riccio A; Danø K; Unsgaard G; Andreasen PA
    Mol Cell Endocrinol; 1989 Jan; 61(1):87-96. PubMed ID: 2501120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
    Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
    J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
    Gyetko MR; Webb AC; Sitrin RG
    J Immunol; 1988 Oct; 141(8):2693-8. PubMed ID: 3139763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines.
    Quax PH; van Leeuwen RT; Verspaget HW; Verheijen JH
    Cancer Res; 1990 Mar; 50(5):1488-94. PubMed ID: 2105839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo.
    Quax PH; van den Hoogen CM; Verheijen JH; Padro T; Zeheb R; Gelehrter TD; van Berkel TJ; Kuiper J; Emeis JJ
    J Biol Chem; 1990 Sep; 265(26):15560-3. PubMed ID: 2118527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
    Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor 1 on the surface of endothelial cells.
    Sakata Y; Okada M; Noro A; Matsuda M
    J Biol Chem; 1988 Feb; 263(4):1960-9. PubMed ID: 3123483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forskolin down-regulates type-1 plasminogen activator inhibitor and tissue-type plasminogen activator and their mRNAs in human fibrosarcoma cells.
    Georg B; Riccio A; Andreasen P
    Mol Cell Endocrinol; 1990 Aug; 72(2):103-10. PubMed ID: 1704320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid induction of plasminogen activator and plasminogen activator-inhibitor messenger RNA in rat hepatoma cells.
    Heaton JH; Gelehrter TD
    Mol Endocrinol; 1989 Feb; 3(2):349-55. PubMed ID: 2469009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression and localization of urokinase-type plasminogen activator and its type 1 inhibitor are regulated by retinoic acid and fibroblast growth factor in human teratocarcinoma cells.
    Tienari J; Alanko T; Lehtonen E; Saksela O
    Cell Regul; 1991 Apr; 2(4):285-97. PubMed ID: 1905574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat alveolar epithelial cells concomitantly express plasminogen activator inhibitor-1 and urokinase.
    Gross TJ; Simon RH; Kelly CJ; Sitrin RG
    Am J Physiol; 1991 Apr; 260(4 Pt 1):L286-95. PubMed ID: 1902065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid modulation of plasminogen activators and of one of their inhibitors in the human mammary carcinoma cell line MDA-MB-231.
    Busso N; Belin D; Failly-Crépin C; Vassalli JD
    Cancer Res; 1987 Jan; 47(2):364-70. PubMed ID: 3098408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid regulation of plasminogen activator inhibitor-1 messenger ribonucleic acid and protein in normal and malignant rat osteoblasts.
    Fukumoto S; Allan EH; Zeheb R; Gelehrter TD; Martin TJ
    Endocrinology; 1992 Feb; 130(2):797-804. PubMed ID: 1733726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha.
    Sawdey M; Podor TJ; Loskutoff DJ
    J Biol Chem; 1989 Jun; 264(18):10396-401. PubMed ID: 2499579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells.
    Genton C; Kruithof EK; Schleuning WD
    J Cell Biol; 1987 Mar; 104(3):705-12. PubMed ID: 3102504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
    Allan EH; Martin TJ
    J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells.
    van Hinsbergh VW; van den Berg EA; Fiers W; Dooijewaard G
    Blood; 1990 May; 75(10):1991-8. PubMed ID: 2140060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
    Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
    J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.